Dennis M. Brown - 30 Aug 2023 Form 4 Insider Report for Kintara Therapeutics, Inc. (KTRA)

Role
Chief Scientific Officer
Signature
/s/ Dennis M. Brown
Issuer symbol
KTRA
Transactions as of
30 Aug 2023
Net transactions value
$0
Form type
4
Filing time
01 Sep 2023, 19:00:30 UTC
Previous filing
06 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTRA Options (Right to Buy) Award $0 +10,175 $0.000000 10,175 30 Aug 2023 Common Stock 10,175 $4.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued employment, 25% of the options vest on August 30, 2024, with the remaining shares vesting in 36 equal monthly installments commencing on September 30, 2024.